Merck & Co has a lower P/E than the aggregate P/E of 57.45 of the Pharmaceuticals industry. Ideally, one might believe that ...

What Happened? Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 4.1% in the afternoon session after Wells ...

Merck ($MRK) stock rose about 4% on Monday, as of writing, after top Wells Fargo analyst Mohit Bansal upgraded his rating for the pharma company ...

Merck (MRK) has quietly pulled ahead of many pharma peers, with the stock climbing about 22% over the past month and 20% in the past 3 months, drawing fresh attention to its valuation. See our latest ...

Pharmaceutical stock Merck & Co (NYSE:MRK) is up 4% at $101.64 at last glance, after an upgrade from Wells Fargo to "overweight" from "equal weight," with a price-target hike to $125 from $90. The ...

Members of Congress have traded $MRK stock 15 times in the past 6 months. Of those trades, 6 have been purchases and 9 have been sales. Here’s a breakdown of recent ...

Merck (NYSE: MRK) recently announced its first-quarter results, exceeding Wall Street’s expectations for both earnings and revenue. The company reported revenues of $15.53 billion and adjusted ...

Investors in Merck & Co Inc (Symbol: MRK) saw new options begin trading today, for the September 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK ...

Merck stock slumps 38% YoY; Q1 earnings could be a pivotal turning point. Analysts see 29% upside despite bearish technicals and weak recent performance. Up Next: Get 5 Dark Horse Stocks Wall Street ...

Merck (MRK) stock in focus as the company urges shareholders to reject a mini-tender offer which stands at a 25% discount to MRK share price on Nov. 7. Read more here.